ASCO 2019: Breast cancer drug effective in 80 per cent of men with BRCA-mutant prostate cancer 05 Jun 2019 A pioneering gene-targeted drug already licensed for breast and ovarian cancer can benefit some men with prostate cancer, a major new clinical trial reports. Find out more Show/Hide
ASCO 2019: Immunotherapy better than aggressive chemotherapy as first treatment option for recurrent head and neck cancer 04 Jun 2019 Immunotherapy used with chemotherapy or on its own is a better first-line treatment for people with head and neck cancer that has returned than standard aggressive chemotherapy, new clinical trial results show. Find out more Show/Hide
ASCO 2019: New blood test predicts breast cancer’s return at start of treatment 02 Jun 2019 A new blood test for women with breast cancer can predict how well patients will respond to a new drug right at the start of treatment. Find out more Show/Hide
ASCO 2017: Adding abiraterone to standard treatment improves prostate cancer survival by almost 40% 03 Jun 2017